Drug Shortage Report for MYLAN-BUDESONIDE AQ

Last updated on 2020-01-21 History
Report ID 23166
Drug Identification Number 02230648
Brand name MYLAN-BUDESONIDE AQ
Common or Proper name BUDESONIDE AQ
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) BUDESONIDE
Strength(s) 100MCG
Dosage form(s) SPRAY, METERED DOSE
Route of administration NASAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 165
ATC code R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-04-16
Actual start date 2018-04-16
Estimated end date 2020-01-30
Actual end date 2020-01-20
Shortage status Resolved
Updated date 2020-01-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v52 2018-01-22 English Compare
v51 2018-01-17 French Compare
v50 2018-01-17 English Compare
v49 2018-01-15 French Compare
v48 2018-01-15 English Compare
v47 2018-01-13 English Compare
v46 2018-01-12 French Compare
v45 2018-01-12 English Compare
v44 2018-01-08 French Compare
v43 2018-01-08 English Compare
v42 2018-01-02 French Compare
v41 2018-01-02 English Compare
v40 2017-12-18 French Compare
v39 2017-12-18 English Compare
v38 2017-12-14 French Compare
v37 2017-12-14 English Compare
v36 2017-12-11 French Compare
v35 2017-12-11 English Compare
v34 2017-12-04 French Compare
v33 2017-12-04 English Compare

Showing 81 to 100 of 132